COMGEST GLOBAL INVESTORS S.A.S. - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 154 filers reported holding WUXI PHARMATECH CAYMAN INC in Q2 2015. The put-call ratio across all filers is 3.79 and the average weighting 0.4%.

Quarter-by-quarter ownership
COMGEST GLOBAL INVESTORS S.A.S. ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q2 2015$69,711,000
-12.7%
1,649,580
-19.9%
2.32%
-6.9%
Q1 2015$79,816,000
+30.3%
2,058,180
+13.1%
2.49%
+33.1%
Q4 2014$61,279,0001,819,9801.87%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q2 2015
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 448,361$15,096,00021.12%
Sloane Robinson LLP 107,400$3,616,0006.28%
Sensato Investors LLC 327,754$11,035,0003.26%
Grandeur Peak Global Advisors, LLC 388,810$13,091,0002.94%
GRATRY & Co LLC 205,800$7,899,0002.59%
THOMAS WHITE INTERNATIONAL LTD 464,926$15,654,0002.15%
COMGEST GLOBAL INVESTORS S.A.S. 1,819,980$61,279,0001.87%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,169,686$39,383,0001.64%
Ninety One North America, Inc. 133,372$4,491,0001.32%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 87,560$2,948,0001.27%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders